Skip to content

Clinical trials

Adenocarcinoma trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma Country / region: Germany Clear all

57 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20052
20063
20071
20083
20093
20103
20115
20121
20131
20144
20153
20166
20172
20181
20191
20204
20212
20221
20231
20242
20253
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28
Terminated10
Recruiting8
Active, not recruiting5
Unknown status3
Not yet recruiting1
Enrolling by invitation1
Available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
AIO-Studien-gGmbH3
Astellas Pharma Global Development, Inc.3
AstraZeneca2
Eli Lilly and Company2
Hoffmann-La Roche2
PD Dr Markus Möhler2
Abbott1
Ariad Pharmaceuticals1
Australasian Gastro-Intestinal Trials Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma57
Neoplasms16
Carcinoma12
Carcinoma, Non-Small-Cell Lung10
Stomach Neoplasms9
Digestive System Neoplasms8
Neoplasms by Histologic Type8
Neoplasms by Site8
Digestive System Diseases6
Lung Neoplasms6

Trials

Showing 76 to 57 of 57. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.